Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Maha Ahmad, M.D.
EIR
•Maha Ahmad, M.D.•August 13, 2021

Maha Ahmad, M.D. – FDA EIR, Aug 13, 2021

Record Details

An FDA surveillance inspection was conducted on clinical investigator Maha Ahmad, M.D., operating in conjunction with Clinilabs Drug Development Corporation, from August 9 to August 13, 2021. This initial inspection focused on study conduct for an investigational new drug (IND 128789) protocol, governed by the Food, Drug, and Cosmetic Act and the Compliance Program for Clinical Investigators (7348.811). The inspection reviewed various aspects of the clinical trial, including subject eligibility, informed consent, and investigational product control. Several record discrepancies were noted. These included the enrollment of two subjects despite initially not meeting inclusion criteria, which personnel attributed to subject unfamiliarity with a 24-hour time reporting system. Further issues involved inconsistencies between source and background records for PK collection times and specific visit data, as well as a medical history item appearing in source records but not in background documentation. The site also lacked current access to the Electronic Data Capture system for complete data verification, and limited documentation was available for investigational product shipments, with only return shipping records provided. During the close-out meeting, these identified discrepancies were discussed with Dr. Ahmad and her management team. Crucially, the inspection concluded without the issuance of an FDA Form 483 (Inspectional Observations), indicating that the observed conditions did not meet the threshold for formal objectionable findings requiring immediate corrective action under regulatory standards. No formal warnings or enforcement actions were issued. The inspection report will be reviewed and classified by the Center for Drug Evaluation and Research.

Company
Maha Ahmad, M.D.
Inspection date
August 13, 2021
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Kathy Kemp (company_representative)
  • Veronica J. Spanola (company_representative)
  • Eileen McAuley (recipient)
  • Omadevi Somai
  • Maha Ahmad (recipient)
View Company Profile

ID · 2035793e-177f-4fb7-b18f-bb90f8bcb7b8

Violation Codes2
21 CFR 50.25(c)21 CFR 312

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Maha Ahmad, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.